Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Samuel Gellman
University of Wisconsin Madison, Department: Chemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Longevity Biotech, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research. The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Backbone-modified agonists of B-family GPCRs
PROJECT NARRATIVE The proposed research focuses on novel molecules that are intended to send biomedically important signals to living cells. These molecules engage receptor proteins located on the external surfaces of cells. Such receptors control many important aspects of physiology, including levels of glucose, calcium and phosphate in the bloodstream, and the function of specific cell types, such as pancreatic ?-cells (which produce insulin) and osteoblasts (which lay down new bone). Peptides that activate specific members of the target receptor class have been developed as drugs, including exenatide, lixisenatide and liraglutide, which are used to treat type 2 diabetes, and teriparatide, which is used to treat osteoporosis. Our research might ultimately lay a foundation for new treatments of these and other human diseases.
Filed on February 27, 2018.
Tell us what you know about Samuel Gellman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Samuel Gellman filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Samuel Gellman | Emory University | Conflict of Interest | Longevity Biotech, Inc. | $0 - $4,999 |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | $0 - $4,999 |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
| Samuel Gellman | University of Wisconsin Madison | Conflict of Interest | Longevity Biotech, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.